These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 11486996)

  • 1. Oral contraceptives, hormone replacement therapy and thrombosis.
    Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Thromb Haemost; 2001 Jul; 86(1):112-23. PubMed ID: 11486996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
    Waselenko JK; Nace MC; Alving B
    Semin Thromb Hemost; 1998; 24 Suppl 1():33-9. PubMed ID: 9840690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens, progestogens and thrombosis.
    Rosendaal FR; Van Hylckama Vlieg A; Tanis BC; Helmerhorst FM
    J Thromb Haemost; 2003 Jul; 1(7):1371-80. PubMed ID: 12871270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female hormones and thrombosis.
    Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):201-10. PubMed ID: 11834517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hormonal changes in women on hemostasis].
    Malý J; Dulícek P
    Vnitr Lek; 2002 Dec; 48(12):1169-73. PubMed ID: 12642936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and myocardial infarction: new evidence leaves unanswered questions.
    Thorogood M
    Thromb Haemost; 1997 Jul; 78(1):334-8. PubMed ID: 9198175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20. Oral contraceptives, hormone replacement therapy and breast cancer.
    Fentiman IS
    Int J Clin Pract; 2002 Dec; 56(10):755-9. PubMed ID: 12510949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal treatment in women and thrombosis].
    Kaaja R; Heikinheimo O; Rasi V
    Duodecim; 1999; 115(11):1235-43. PubMed ID: 11877844
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboembolism during hormone therapy in Japanese women.
    Adachi T; Sakamoto S
    Semin Thromb Hemost; 2005 Jun; 31(3):272-80. PubMed ID: 16052396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Venous and arterial thrombotic events induced by synthetic-steroid hormones or oral contraceptives].
    Sugawara H; Kawakami M
    Nihon Rinsho; 1999 Jul; 57(7):1657-64. PubMed ID: 10429474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors].
    Drouet L
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormones and thrombosis.
    Watson HG
    Semin Hematol; 2007 Apr; 44(2):98-105. PubMed ID: 17433902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial infarction and oral contraceptives].
    Bounhoure JP; Galinier M; Roncalli J; Assoun B; Puel J
    Bull Acad Natl Med; 2008 Mar; 192(3):569-79; discussion 579. PubMed ID: 18819701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.